SEARCH

SEARCH BY CITATION

REFERENCES

  • Akhan O, Karaosmanoglu AD, Ergen B. 2007. Imaging findings in congenital hepatic fibrosis. Eur J Radiol 61: 18124.
  • Alvarez F, Bernard O, Brunelle F, Hadchouel M, Leblanc A, Odievre M, Alagille D. 1981. Congenital hepatic fibrosis in children. J Pediatr 99: 370375.
  • Anon. 1994. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium. Cell 78: 725.
  • Arnold HL, Harrison SA. 2005. New advances in evaluation and management of patients with polycystic liver disease. Am J Gastroenterol 100: 25692582.
    Direct Link:
  • Avner ED, Sweeney WE Jr. 2006. Renal cystic disease: New insights for the clinician. Pediatr Clin North Am 53: 889909, ix.
  • Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, Baumgarten DA, King BF Jr, Wetzel LH, Kenney PJ, et al. 2006. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Clin J Am Soc Nephrol 1: 6469.
  • Bergmann C, Senderek J, Kupper F, Schneider F, Dornia C, Windelen E, Eggermann T, Rudnik-Schoneborn S, Kirfel J, Furu L, et al. 2004. PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD). Hum Mutat 23: 453463.
  • Bergmann C, Kupper F, Dornia C, Schneider F, Senderek J, Zerres K. 2005. Algorithm for efficient PKHD1 mutation screening in autosomal recessive polycystic kidney disease (ARPKD). Hum Mutat 25: 225231.
  • Bernstein J, Chandra M, Creswell J, Kahn E, Malouf NN, McVicar M, Weinberg AG, Wybel RE. 1987. Renal-hepatic-pancreatic dysplasia: A syndrome reconsidered. Am J Med Genet 26: 391403.
  • Bingham C, Bulman MP, Ellard S, Allen LI, Lipkin GW, Hoff WG, Woolf AS, Rizzoni G, Novelli G, Nicholls AJ, Hattersley AT. 2001. Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet 68: 219224.
  • Bisceglia M, Galliani CA, Senger C, Stallone C, Sessa A. 2006. Renal cystic diseases: A review. Adv Anat Pathol 13: 2656.
  • Bloustein PA. 1977. Association of carcinoma with congenital cystic conditions of the liver and bile ducts. Am J Gastroenterol 67: 4046.
  • Boichis H, Passwell J, David R, Miller H. 1973. Congenital hepatic fibrosis and nephronophthisis. A family study. Q J Med 42: 221233.
  • Brun M, Maugey-Laulom B, Eurin D, Didier F, Avni EF. 2004. Prenatal sonographic patterns in autosomal dominant polycystic kidney disease: A multicenter study. Ultrasound Obstet Gynecol 24: 5561.
  • Capisonda R, Phan V, Traubuci J, Daneman A, Balfe JW, Guay-Woodford LM. 2003. Autosomal recessive polycystic kidney disease: Outcomes from a single-center experience. Pediatr Nephrol 18: 119126.
  • Caroli J. 1968. Diseases of intrahepatic bile ducts. Isr J Med Sci 4: 2135.
  • Caroli J. 1973. Diseases of the intrahepatic biliary tree. Clin Gastroenterol 2: 147161.
  • Davila S, Furu L, Gharavi AG, Tian X, Onoe T, Qian Q, Li A, Cai Y, Kamath PS, King BF, Azurmendi PJ, Tahvanainen P, Kääriäinen H, Höckerstedt K, Devuyst O, Pirson Y, Martin RS, Lifton RP, Tahvanainen E, Torres VE, Somlo S. 2004. Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet 36: 575577.
  • de Bruyn R, Marks SD. 2008. Postnatal investigation of fetal renal disease. Semin Fetal Neonatal Med 13: 133141.
  • Delaney V, Mullaney J, Bourke E. 1978. Juvenile nephronophthisis, congenital hepatic fibrosis and retinal hypoplasia in twins. Q J Med 47: 281290.
  • Dell KM, Avner ED. 2008. Autosomal recessive polycystic kidney disease. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online) Copyright, University of Washington, Seattle 1997–2008. Available at http://wwwgenetestsorg.
  • Desmet VJ. 1992a. Congenital diseases of intrahepatic bile ducts: Variations on the theme “ductal plate malformation”. Hepatology 16: 10691083.
  • Desmet VJ. 1992b. What is congenital hepatic fibrosis? Histopathology 20: 465477.
  • Desmet VJ. 1998. Ludwig symposium on biliary disorders—Part I. Pathogenesis of ductal plate abnormalities. Mayo Clin Proc 73: 8089.
  • Doherty D, Parisi MA, Finn LS, Gunay-Aygun M, Al-Mateen M, Bates D, Clericuzio C, Demir H, Dorschner M, van Essen A, Gahl WA, Gentile M, Gorden NT, Hikida A, Knutzen D, Ozyurek H, Phelps I, Rosenthal P, Verloes A, Weigand H, Chance PF, Dobyns WB, Glass IA. 2009. Mutations in 3 genes (MKS3, CC2D2A and RPGRIPIL) cause coach syndrome (Joubert syndrome with congenital hepatic fibrosis). J Med Genet.
  • Drenth JP, te Morsche RH, Smink R, Bonifacino JS, Jansen JB. 2003. Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat Genet 33: 345347.
  • Drenth JP, Martina JA, van de Kerkhof R, Bonifacino JS, Jansen JB. 2005. Polycystic liver disease is a disorder of cotranslational protein processing. Trends Mol Med 11: 3742.
  • Everson GT, Taylor MR. 2005. Management of polycystic liver disease. Curr Gastroenterol Rep 7: 1925.
  • Fliegauf M, Benzing T, Omran H. 2007. When cilia go bad: Cilia defects and ciliopathies. Nat Rev Mol Cell Biol 8: 880893.
  • Fonck C, Chauveau D, Gagnadoux MF, Pirson Y, Grunfeld JP. 2001. Autosomal recessive polycystic kidney disease in adulthood. Nephrol Dial Transplant 16: 16481652.
  • Fraser FC, Lytwyn A. 1981. Spectrum of anomalies in the Meckel syndrome, or: “Maybe there is a malformation syndrome with at least one constant anomaly”. Am J Med Genet 9: 6773.
  • Gabow P. 1996. Definition and natural history of autosomal dominant polycystic kidney disease. In: WatsonML, TorresVE, editors. Polycystic kidney disease. Oxford: Oxford University Press. pp 333355.
  • Germino GG. 1997. Autosomal dominant polycystic kidney disease: A two-hit model. Hosp Pract (Minneap) 32: 8182, 85–88, 91–92 passim.
  • Goilav B, Norton KI, Satlin LM, Guay-Woodford L, Chen F, Magid MS, Emre S, Shneider BL. 2006. Predominant extrahepatic biliary disease in autosomal recessive polycystic kidney disease: A new association. Pediatr Transplant 10: 294298.
  • Grantham JJ, Chapman AB, Torres VE. 2006. Volume progression in autosomal dominant polycystic kidney disease: The major factor determining clinical outcomes. Clin J Am Soc Nephrol 1: 148157.
  • Guay-Woodford LM, Desmond RA. 2003. Autosomal recessive polycystic kidney disease: The clinical experience in North America. Pediatrics 111: 10721080.
  • Gunay-Aygun M, Gahl WA, Heller T. 2008. Congenital hepatic fibrosis overview. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online) Copyright, University of Washington, Seattle 1997–2008. Available at http://wwwgenetestsorg.
  • Gunay-Aygun M, Avner ED, Bacallao RL, Choyke PL, Flynn JT, Germino GG, Guay-Woodford L, Harris P, Heller T, Ingelfinger J, Kaskel F, Kleta R, LaRusso NF, Mohan P, Pazour GJ, Shneider BL, Torres VE, Wilson P, Zak C, Zhou J, Gahl WA. 2006. Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: Summary statement of a first National Institutes of Health/Office of Rare Diseases conference. J Pediatr 149: 159164.
  • Gunay-Aygun M, Parisi M, Doherty D, Tuchman M, Tsilou E, Kleiner DE, Huizing M, Turkbey B, Choyke P, Guay-Woodford L, Heller T, Szymanska K, Johnson CA, Glass I, Gahl WA. 2009. MKS3-related Ciliopathy with Features of Autosomal Recessive Polycystic Kidney Disease, Nephronophthisis and Joubert Syndrome. J Pediatr 155: 386392.
  • Gurrieri F, Franco B, Toriello H, Neri G. 2007. Oral-facial-digital syndromes: Review and diagnostic guidelines. Am J Med Genet Part A 143A: 33143323.
  • Harnett JD, Green JS, Cramer BC, Johnson G, Chafe L, McManamon P, Farid NR, Pryse-Phillips W, Parfrey PS. 1988. The spectrum of renal disease in Laurence-Moon-Biedl syndrome. N Engl J Med 319: 615618.
  • Harris PC, Torres VE. 2008. Polycystic Kidney Disease, Autosomal Dominant, In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online) Copyright, University of Washington, Seattle 1997–2008. Available at http://wwwgenetestsorg.
  • Harris PC, Torres VE. 2009. Polycystic kidney disease. Annual Rev Med 60: 321337.
  • Hateboer N, v Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D. 1999. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 353: 103107.
  • Hildebrandt F, Zhou W. 2007. Nephronophthisis-associated ciliopathies. J Am Soc Nephrol 18: 18551871.
  • Hildebrandt F, Attanasio M, Otto E. 2009. Nephronophthisis: Disease mechanisms of a ciliopathy. J Am Soc Nephrol 20: 2335.
  • Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI. 1997. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 17: 384385.
  • Hudgins L, Rosengren S, Treem W, Hyams J. 1992. Early cirrhosis in survivors with Jeune thoracic dystrophy. J Pediatr 120: 754756.
  • Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC. 1995. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10: 151160.
  • Hurley RM, Dery P, Norady MB, Drummond KN. 1975. The renal lesion of the Laurence-Moon-Biedl syndrome. J Pediatr 87: 206209.
  • Johnson CA, Gissen P, Sergi C. 2003. Molecular pathology and genetics of congenital hepatorenal fibrocystic syndromes. J Med Genet 40: 311319.
  • Jorgensen MJ. 1977. The ductal plate malformation. Acta Pathol Microbiol Scand Suppl 257: 187.
  • Kerkar N, Norton K, Suchy FJ. 2006. The hepatic fibrocystic diseases. Clin Liver Dis 10: 5571, v–vi.
  • Kerr DN, Harrison CV, Sherlock S, Walker RM. 1961. Congenital hepatic fibrosis. Q J Med 30: 91117.
  • Kerr DN, Okonkwo S, Choa RG. 1978. Congenital hepatic fibrosis: The long-term prognosis. Gut 19: 514520.
  • Labrune P, Fabre M, Trioche P, Estournet-Mathiaud B, Grangeponte MC, Rambaud C, Maurage C, Bernard O. 1999. Jeune syndrome and liver disease: Report of three cases treated with ursodeoxycholic acid. Am J Med Genet 87: 324328.
  • Lewis SM, Roberts EA, Marcon MA, Harvey E, Phillips MJ, Chuang SA, Buncic JR, Clarke JT. 1994. Joubert syndrome with congenital hepatic fibrosis: An entity in the spectrum of oculo-encephalo-hepato-renal disorders. Am J Med Genet 52: 419426.
  • Li A, Davila S, Furu L, Qian Q, Tian X, Kamath PS, King BF, Torres VE, Somlo S. 2003. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am J Hum Genet 72: 691703.
  • Limwongse CCS, Cassidy SB. 1999. Syndromes and malformations of the urinary tract. In: BarrattTM, AvnerED, HarmonWE, editors. Pediatric nephrology. Baltimore: Lippincott Williams & Wilkins. pp 427452.
  • Linne T, Wikstad I, Zetterstrom R. 1986. Renal involvement in the Laurence-Moon-Biedl syndrome. Functional and radiological studies. Acta Paediatr Scand 75: 240244.
  • Masyuk AI, Masyuk TV, Splinter PL, Huang BQ, Stroope AJ, LaRusso NF. 2006. Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling. Gastroenterology 131: 911920.
  • Masyuk AI, Masyuk TV, LaRusso NF. 2008. Cholangiocyte primary cilia in liver health and disease. Dev Dyn 237: 20072012.
  • Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S. 1996. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 13391342.
  • Morgan DE, Lockhart ME, Canon CL, Holcombe MP, Bynon JS. 2006. Polycystic liver disease: Multimodality imaging for complications and transplant evaluation. Radiographics 26: 16551668; quiz 1655.
  • Nakamura F, Sasaki H, Kajihara H, Yamanoue M. 1990. Laurence-Moon-Biedl syndrome accompanied by congenital hepatic fibrosis. J Gastroenterol Hepatol 5: 206210.
  • Nicolau CTR, Badenas C, Vilana R, Bianchi L, Gilabert R, Darnell A, Bru C. 1999. Autosomal dominant polycystic kidney disease types 1 and 2: Assessment of US sensitivity for diagnosis. Radiology 213: 273276.
  • O'Dea D, Parfrey PS, Harnett JD, Hefferton D, Cramer BC, Green J. 1996. The importance of renal impairment in the natural history of Bardet-Biedl syndrome. Am J Kidney Dis 27: 776783.
  • Olbrich H, Fliegauf M, Hoefele J, Kispert A, Otto E, Volz A, Wolf MT, Sasmaz G, Trauer U, Reinhardt R, Sudbrak R, Antignac C, Gretz N, Walz G, Schermer B, Benzing T, Hildebrandt F, Omran H. 2003. Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis. Nat Genet 34: 455459.
  • Omran HaE-OB. 2008. Nephronophithisis and medullary cystic kidney disease. In: GearyDF, SchaeferF, editors. Comprehensive pediatric nephrology. Elsiever. pp 143154.
  • Onuchic LF, Furu L, Nagasawa Y, Hou X, Eggermann T, Ren Z, Bergmann C, Senderek J, Esquivel E, Zeltner R, Rudnik-Schöneborn S, Mrug M, Sweeney W, Avner ED, Zerres K, Guay-Woodford LM, Somlo S, Germino GG. 2002. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet 70: 13051317.
  • Osathanondh V, Potter EL. 1964. Pathogenesis of polycystic kidneys. Historical survey. Arch Pathol 77: 459465.
  • Otto EA, Tory K, Attanasio M, Zhou W, Chaki M, Paruchuri Y, Wise EL, Wolf MTF, Utsch B, Becker C, Nürnberg G, Nürnberg P, Nayir A, Saunier S, Antignac C, Hildebrandt F. 2009. Hypomorphic mutations in meckelin (MKS3/TMEM67) cause nephronophthisis with liver fibrosis (NPHP11). Journal of Medical Genetics 46: 663670.
  • Ozcay F, Derbent M, Demirhan B, Tokel K, Saatci U. 2001. A family with Jeune syndrome. Pediatr Nephrol 16: 623626.
  • Pagon RA, Haas JE, Bunt AH, Rodaway KA. 1982. Hepatic involvement in the Bardet-Biedl syndrome. Am J Med Genet 13: 373381.
  • Parisi MA, Doherty D, Chance PF, Glass IA. 2007. Joubert syndrome (and related disorders) (OMIM 213300). Eur J Hum Genet 15: 511521.
  • Patel V, Chowdhury R, Igarashi P. 2009. Advances in the pathogenesis and treatment of polycystic kidney disease. Curr Opin Nephrol Hypertens 18: 99106.
  • Prattichizzo C, Macca M, Novelli V, Giorgio G, Barra A, Franco B. 2008. Mutational spectrum of the oral-facial-digital type I syndrome: A study on a large collection of patients. Hum Mutat 29: 12371246.
  • Rodat-Despoix L, Delmas P. 2009. Ciliar functions in the nephron. Pflugers Arch 458: 179187.
  • Rossetti S, Harris PC. 2007. Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease. J Am Soc Nephrol 18: 13741380.
  • Rossetti S, Burton S, Strmecki L, Pond GR, San Millan JL, Zerres K, Barratt TM, Ozen S, Torres VE, Bergstralh EJ, Winearls CG, Harris PC. 2002. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol 13: 12301237.
  • Rossetti S, Chauveau D, Kubly V, Slezak JM, Saggar-Malik AK, Pei Y, Ong AC, Stewart F, Watson ML, Bergstralh EJ, Winearls CG, Torres VE, Harris PC. 2003a. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 361: 21962201.
  • Rossetti S, Torra R, Coto E, Consugar M, Kubly V, Malaga S, Navarro M, El-Youssef M, Torres VE, Harris PC. 2003b. A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees. Kidney Int 64: 391403.
  • Roy S, Dillon MJ, Trompeter RS, Barratt TM. 1997. Autosomal recessive polycystic kidney disease: Long-term outcome of neonatal survivors. Pediatr Nephrol 11: 302306.
  • Salomon R, Saunier S, Niaudet P. 2008. Nephronophthisis. Pediatr Nephrol. July 8 [Epub ahead of print].
  • Satran D, Pierpont ME, Dobyns WB. 1999. Cerebello-oculo-renal syndromes including Arima, Senior-Loken and COACH syndromes: More than just variants of Joubert syndrome. Am J Med Genet 86: 459469.
  • Shah KJ. 1980. Renal lesion in Jeune's syndrome. Br J Radiol 53: 432436.
  • Shedda S, Robertson A. 2007. Caroli's syndrome and adult polycystic kidney disease. ANZ J Surg 77: 292294.
  • Silverstein DM, Zacharowicz L, Edelman M, Lee SC, Greifer I, Rapin I. 1997. Joubert syndrome associated with multicystic kidney disease and hepatic fibrosis. Pediatr Nephrol 11: 746749.
  • Summerfield JANY, Sherlock S, Canafalch J, Scheuer PJ. 1986. Hepatobiliary fibropolycystic disease: A clinical and histological review of 51 patients. J Hepatol 2: 141156.
  • Sweeney WE Jr, Avner ED. 2006. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD). Cell Tissue Res 326: 671685.
  • Tahvanainen P, Tahvanainen E, Reijonen H, Halme L, Kaariainen H, Hockerstedt K. 2003. Polycystic liver disease is genetically heterogeneous: Clinical and linkage studies in eight Finnish families. J Hepatol 38: 3943.
  • Tahvanainen E, Tahvanainen P, Kaariainen H, Hockerstedt K. 2005. Polycystic liver and kidney diseases. Ann Med 37: 546555.
  • Thauvin-Robinet C, Cossee M, Cormier-Daire V, Van Maldergem L, Toutain A, Alembik Y, Bieth E, Layet V, Parent P, David A, Goldenberg A, Mortier G, Héron D, Sagot P, Bouvier AM, Huet F, Cusin V, Donzel A, Devys D, Teyssier JR, Faivre L. 2006. Clinical, molecular, and genotype-phenotype correlation studies from 25 cases of oral-facial-digital syndrome type 1: A French and Belgian collaborative study. J Med Genet 43: 5461.
  • Toprak O, Uzum A, Cirit M, Esi E, Inci A, Ersoy R, Tanrisev M, Ok E, Franco B. 2006. Oral-facial-digital syndrome type 1, Caroli's disease and cystic renal disease. Nephrol Dial Transplant 21: 17051709.
  • Torra R, Alos L, Ramos J, Estivill X. 1996. Renal-hepatic-pancreatic dysplasia: An autosomal recessive malformation. J Med Genet 33: 409412.
  • Uemura T, Sanchez EQ, Ikegami T, Watkins D, Narasimhan G, McKenna GJ, Chinnakotla S, Dawson S III, Randall HB, Levy MF, Goldstein RM, Klintmalm GB. 2005. Successful combined liver and kidney transplant for COACH syndrome and 5-yr follow-up. Clin Transplant 19: 717720.
  • Veland IR, Awan A, Pedersen LB, Yoder BK, Christensen ST. 2009. Primary cilia and signaling pathways in mammalian development, health and disease. Nephron Physiol 111: 3953.
  • Waanders E, te Morsche RH, de Man RA, Jansen JB, Drenth JP. 2006. Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease. Hum Mutat 27: 830.
  • Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X, Kubly V, Cunningham JM, Bacallao R, Ishibashi M, Milliner DS, Torres VE, Harris PC. 2002. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 30: 259269.
  • Watkins SL MR, Avner ED. 1999. Renal dysplasia, hypoplasia and miscellaneous cystic disorders. In: BarrattTM, AvnerED, HarmonWE, editors. Pediatric nephrology. Baltimore: Lippincott Williams & Wilkins. pp 415425.
  • White SM, Hurst JA, Hamoda H, Chamberlain P, Bowker CM. 2000. Renal-hepatic-pancreatic dysplasia: A broad entity. Am J Med Genet 95: 399400.
  • Wilson PD. 2004. Polycystic kidney disease. N Engl J Med 350: 151164.
  • Yamato T, Sasaki M, Hoso M, Sakai J, Ohta H, Watanabe Y, Nakanuma Y. 1998. Intrahepatic cholangiocarcinoma arising in congenital hepatic fibrosis: Report of an autopsy case. J Hepatol 28: 717722.
  • Yerian LM, Brady L, Hart J. 2003. Hepatic manifestations of Jeune syndrome (asphyxiating thoracic dystrophy). Semin Liver Dis 23: 195200.
  • Zerres K, Volpel MC, Weiss H. 1984. Cystic kidneys. Genetics, pathologic anatomy, clinical picture, and prenatal diagnosis. Hum Genet 68: 104135.
  • Zerres K, Rudnik-Schoneborn S, Deget F, Holtkamp U, Brodehl J, Geisert J, Scharer K. 1996. Autosomal recessive polycystic kidney disease in 115 children: Clinical presentation, course and influence of gender. Arbeitsgemeinschaft fur Padiatrische, Nephrologie. Acta Paediatr 85: 437445.
  • Zerres K, Mucher G, Becker J, Steinkamm C, Rudnik-Schoneborn S, Heikkila P, Rapola J, Salonen R, Germino GG, Onuchic L, Somlo S, Avner ED, Harman LA, Stockwin JM, Guay-Woodford LM. 1998. Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): Molecular genetics, clinical experience, and fetal morphology. Am J Med Genet 76: 137144.